Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 126

    1.

    Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?

    Evans DG, Howell A.

    Breast Cancer Res. 2004;6(1):E7.

    PMID:
    14680492
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.

    Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Bégin LR, Offit K, Foulkes WD.

    Breast Cancer Res. 2004;6(1):R8-R17. Epub 2003 Oct 24.

    PMID:
    14680495
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.

    Arnes JB, Brunet JS, Stefansson I, Bégin LR, Wong N, Chappuis PO, Akslen LA, Foulkes WD.

    Clin Cancer Res. 2005 Jun 1;11(11):4003-11.

    PMID:
    15930334
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

    Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; for the Institut Curie Breast Cancer Study Group.

    Eur J Cancer. 2005 Oct;41(15):2304-11. Epub 2005 Sep 1.

    PMID:
    16140006
    [PubMed - indexed for MEDLINE]
    5.

    Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.

    Mote PA, Leary JA, Avery KA, Sandelin K, Chenevix-Trench G, Kirk JA, Clarke CL; kConFab Investigators.

    Genes Chromosomes Cancer. 2004 Mar;39(3):236-48.

    PMID:
    14732925
    [PubMed - indexed for MEDLINE]
    6.

    Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type.

    Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Bégin LR, Narod SA.

    Clin Cancer Res. 2004 Mar 15;10(6):2029-34.

    PMID:
    15041722
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment.

    Chappuis PO, Donato E, Goffin JR, Wong N, Bégin LR, Kapusta LR, Brunet JS, Porter P, Foulkes WD.

    Ann Oncol. 2005 May;16(5):735-42. Epub 2005 Mar 31.

    PMID:
    15802279
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.

    van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van't Veer LJ, Tollenaar RA.

    Br J Cancer. 2005 Aug 8;93(3):287-92.

    PMID:
    16052221
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.

    Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS.

    Am J Surg. 2006 Jul;192(1):58-62.

    PMID:
    16769276
    [PubMed - indexed for MEDLINE]
    10.

    BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.

    Friedenson B.

    MedGenMed. 2005 Jun 29;7(2):60.

    PMID:
    16369438
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Conservative management of breast cancer in BRCA1/2 mutation carriers.

    Alpert TE, Haffty BG.

    Clin Breast Cancer. 2004 Apr;5(1):37-42. Review.

    PMID:
    15140283
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations status.

    Fourquet A, Stoppa-Lyonnet D, Kirova YM, Sigal-Zafrani B, Asselain B; Institut Curie Breast Cancer Study Group; Institut Curie Breast Ovary Cancer Risk Study Group.

    Am J Clin Oncol. 2009 Apr;32(2):127-31.

    PMID:
    19307946
    [PubMed - indexed for MEDLINE]
    13.

    PML protein expression in hereditary and sporadic breast cancer.

    Plevová P, Bouchal J, Fiurásková M, Foretová L, Navrátilová M, Zapletalová J, Curík R, Kubala O, Prokop J, Kolár Z.

    Neoplasma. 2007;54(4):263-8.

    PMID:
    17822314
    [PubMed - indexed for MEDLINE]
    14.

    Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.

    Tilanus-Linthorst MM, Alves C, Seynaeve C, Menke-Pluymers MB, Eggermont AM, Brekelmans CT.

    Br J Surg. 2006 Aug;93(8):961-8.

    PMID:
    16758466
    [PubMed - indexed for MEDLINE]
    15.

    Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

    Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J, Lynch HT, Isaacs C, Weber B, Kim-Sing C, Ainsworth P, Foulkes WD, Eisen A, Sun P, Narod SA.

    Breast Cancer Res. 2005;7(5):R833-43. Epub 2005 Aug 19.

    PMID:
    16168130
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer.

    Hubert A, Mali B, Hamburger T, Rottenberg Y, Uziely B, Peretz T, Kadouri L.

    Fam Cancer. 2009;8(3):173-7. Epub 2008 Nov 19.

    PMID:
    19016350
    [PubMed - indexed for MEDLINE]
    18.

    Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

    McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group.

    Lancet Oncol. 2007 Jan;8(1):26-34.

    PMID:
    17196508
    [PubMed - indexed for MEDLINE]
    19.

    High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.

    Shahedi K, Emanuelsson M, Wiklund F, Gronberg H.

    Cancer. 2006 Mar 15;106(6):1237-42.

    PMID:
    16475207
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

    Narod SA, Lubinski J, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Rosen B, Kim-Sing C, Isaacs C, Domchek S, Sun P; Hereditary Breast Cancer Clinical Study Group.

    Lancet Oncol. 2006 May;7(5):402-6. Erratum in: Lancet Oncol. 2006 Jun;7(6):453. Domcheck, Susan [corrected to Domchek, Susan].

    PMID:
    16648044
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk